Stay updated on Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial page.

Latest updates to the Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded Revision: v3.3.3 to the page history. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry (v3.3.2) was added to the Record History and an older revision (v3.3.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded Revision v3.3.1 to the study record history and removed Revision v3.2.0.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoved the government funding and operating status notice that previously appeared at the top of the page. The rest of the page content remains unchanged.SummaryDifference0.7%

- Check62 days agoChange DetectedThe new screenshot adds several recent history entries (versions 8–11) showing updated study status and QC-returned items. This reflects ongoing updates to the trial record.SummaryDifference0.1%

- Check91 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference11%

Stay in the know with updates to Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial page.